Path Fertility Releases its SpermQT Facts Sheet

March 17, 2026 / Path FertilityTM, an epigenetics-driven fertility technology company, today unveiled its SpermQTTM Facts Sheet, a copy of which is embedded below within this news release.

For Couples in “Fertility Limbo,” a Real-World Study Published by JARG Finds “Normal” Semen Analysis May Not Tell the Whole Story

A peer-reviewed, multi-clinic study published in the Journal of Assisted Reproduction and Genetics suggests an ...
News Medical

Clinical management of patients with Cancer of Unknown Primary using new epigenetic test

The invention of the EPICUP epigenetic test last year allowed physicians to elucidate what type of primary tumor had metastasized in patients with Cancer of Unknown Primary (CUP). Today, an article ...
News Medical

Epigenetic breakthrough: $200 blood test spots diabetes heart risk better than standard tools

A new DNA methylation-based blood test can identify type 2 diabetes patients at the highest risk of heart attack or stroke years in advance, beating traditional risk scores and opening the door to ...
Medical Xpress

Epigenetic drift underlies epigenetic clock signals, but responds uniquely to various factors

A new research paper titled "Epigenetic drift underlies epigenetic clock signals, but displays distinct responses to lifespan interventions, development, and cellular dedifferentiation" has been ...

Path Fertility Releases its Company Facts Sheet

SALT LAKE CITY, UT / ACCESS Newswire / March 10, 2026 / Path FertilityTM, an epigenetics-driven fertility technology ...